Anti-platelet thrombolysin(Zhaoke)
抗血小板溶栓素（兆科药业）
Report date: 2023/05/19 20:00:21
Base Information
Drug NameAnti-platelet thrombolysin(Zhaoke)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhaoke Pharmaceutical (Hefei) Co Ltd Guangzhou Branch
China Registration ClassN/A
Develop Information
Active CompaniesZhaoke Pharmaceutical (Hefei) Co Ltd Guangzhou Branch
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A